top of page
< Back

Dronedarone


Mechanism of action:

Dronedarone is a non-iodinated analogue of amiodarone with multiple ion channel-blocking properties. Dronedarone inhibits potassium channels, including the delayed rectifier potassium currents IKr and IKs in cardiac muscle, thereby prolonging the cardiac action potential and effective refractory period (ERP), which reduces the likelihood of abnormal reentrant conduction. Dronedarone also inhibits sodium channels, slowing phase 0 depolarization and reducing conduction velocity, which helps stabilize the myocardial membrane. In addition, dronedarone inhibits L-type calcium channels, reducing conduction through the sinoatrial node and atrioventricular node.

Reference(s):

1. Schweizer PA et al. (2011). Dronedarone: current evidence for its safety and efficacy in the management of atrial fibrillation. Drug Des Devel Ther. 


2. Patel PD et al. (2009). Dronedarone for atrial fibrillation: a new therapeutic agent. Vasc Health Risk Manag.

bottom of page